At T-NeuroDx, we believe in the power of innovative science.
At T-NeuroDx, our mission is to transform Alzheimer's care by commercializing tests for early detection of the disease. This will expand opportunities for the development of new and more effective therapies, reduce the cost of clinical trials and allow treatment interventions to begin at earlier, more impactful stages.
Our Team
Scientific Advisory Board
Recent News
Press Releases
T-NeuroDx Secures $500,000 NIH Grant to Advance Novel Alzheimer’s Disease Blood Biomarker Research
Press Releases
TrilliumBiO and T-NeuroDx Announce Strategic Collaboration to Commercialize Blood-Based Biomarkers for Alzheimer’s Disease
Media Coverage
FOX40: T-NeuroDx to Present Advances in Blood Test for Early Alzheimer’s Detection at Major Conference
Press Releases
T-NeuroDx to Present Advances in Blood Test for Early Alzheimer’s Detection at Major Conference
Media Coverage
GENOME WEB: Beckman Coulter Life Sciences, T-NeuroDx Collaborate on Early Alzheimer’s Diagnostics
Press Releases
T-NeuroDx and Beckman Coulter Life Sciences to Collaborate on Early Alzheimer’s Disease Research
Press Releases